2.4.4.İ-3- Preimplantation Genetic Diagnosis (PGT) and IVF treatment for the birth of a healthy child
(1) Those who have a healthy child in their current marriage Except for couples. including; SUT annex "List of Hereditary Diseases for which Preimplantation Genetic Diagnosis (PGT) and Invitro Fertilization (IVF) will be performed (ANNEX-2/K)" There is a contractual/protocol for the birth of a healthy child by performing PGD for a married couple who has a hereditary disease or is determined to be a carrier for this disease. thirdü Expenses related to IVF treatments performed based on the medical board report prepared by the primary health care service providers are maximum three if the conditions specified in subparagraphs (b), (c) and (cc) of the first paragraph of Article 2.4.4.I-1 of the SUT are met together. It is covered by the Institution, limited to a trial (cycle).
b) The woman must be older than 23 and younger than 40,
c) The center where the application is made must have a contract/protocol with the Institution; to be,
ç) One of the spouses must have had universal health insurance or a dependent for at least five years. The person is the registered person and the number of general health insurance premium days is 900 days.
(2) The medical board report required for IVF treatment to be applied together with PGT; contractual/protocolü thirdü It will be organized by the health board, which includes the branch physicians specified in the ANNEX-2/K list of the SUT annex, in the primary health care service providers. The health board consists of physicians working in the health service provider.
(3) The medicine determined by the health board report; For doses, the provisions in Article 4.2.42.D of the SUT are valid.
(4) Preimplantation genetic diagnosis and IVF treatment costs for the birth of a healthy child, Diagnoses included in the SUT annex ANNEX-2/K list are covered by the Institution. For these diagnoses, there must be a genetic counseling note signed by the medical geneticist of the married couple and a genetic diagnosis report with clinical interpretation.
(5) For PGT examinations, "Preimplantation Genetic Diagnosis Examinations" coded 908747 in the ANNEX-2/B list, intact çintended for the birth of a child” The process will be invoiced and all operations performed on the preliminary preparation and embryo are included.
(6) Contracted/protocoled with the institution; Embryos suitable for IVF obtained by an assisted reproductive treatment center (in vitro fertilization center) must be numbered at most eight, and with the reports created in this way, the embryos are classified as "healthy", "carrier", "patient" in terms of the disease specified in the genetic diagnosis report. Reports containing the analysis results stated as "must be submitted to the Institution as the basis for examination." The embryo must be transferred.
(8) Since the IVF process for a married couple who has a hereditary disease or is known to be a carrier for this disease to have a healthy child is done with the transfer of healthy embryos determined by PGT, it is three times more important. The number of attempts also applies to PGT. çç In case of trial IVF, PGT right ends.
(9) PGT and IVF right is maximum three; It is limited to the trial.
(10) The freezing process of healthy embryos or embryos obtained by PGT and not transferred is covered by the Institution if the right to try IVF is available.
(11) If the freezing process is carried out with the transfer of the embryo in IVF treatment, the procedures are covered by the SUT annex. "Transfer of the embryo subjected to freezing" in the ANNEX-2/C list; The transaction will be invoiced. In this case, the transaction in question will be included in the number of attempts.”
Article 7- Refer to article 4.2.42 of the same communiqué The following sub-item has been added.
“4.2.42.D- Drugs to be used in Preimplantation Genetic Diagnosis (PGT) and In Vitro Fertilization (IVF) treatment for the birth of healthy children
(1) Drugs to be used in Preimplantation Genetic Diagnosis (PGT) and In Vitro Fertilization (IVF) treatment for the birth of a healthy child; It can be prescribed by gynecology and obstetrics specialist physicians at the reproductive treatment center where PGT and In Vitro Fertilization (IVF) treatment is performed, complying with the conditions of Article 2.4.4.I-3 of the SUT and based on the health board report specified in the said article. The gonadotropin dose to be used for each IVF attempt will be maximum 3000 IU and will be stated in the report. LIST OF HEREDITATIVE DISEASES FOR WHICH GENETIC DIAGNOSIS (PGT) WILL BE DONE WITH INVITRO FERTILIZATION (IVF) (ANNEX-2/K)
|
DIAGNOSIS CODE |
DIEASE NAME |
|
D56.1 |
Beta Thalassemia (MCI, gene)
|
|
D66 |
Hereditary Factor VIII Deficiency (F8, gene)
|
|
D67 |
Hereditary Factor IX Deficiency (F9, gene)
|
|
D81.3 |
Adenosine Deaminase [ADA] Deficiency (ADA, gene)
|
|
E71 |
Branched-Chain Amino Acid Metabolism and Fatty Acid Metabolism Disorders (ACAT1, BCKDHA, BCKDHB, DBT, GCDH, HMGCL, IVD, MCCC1, MCCC2, MCEE, MMAA, MMAB, MMACHC, MMADHC, MMUT, PCCA, PCCB, PRDX1, gene)
|
|
E72.2 |
Recycle Metabolism Disorders (ARG1, ASL, ASS1, CPS1, NAGA, OTR, gene)
|
|
E75 |
Sphingolipid Metabolism Disorders and Other Lipid Storage Disorders (GLA, gene)
|
|
E76.0 |
Mucopolysaccharidoses, Type I (IDUA, gene)
|
|
E76.1 |
Mucopolysaccharidoses, Type II (IDS, geni)
|
|
E76.2 |
Mucopolysaccharidosis, Other (GLB1, HYAL1, ARSB, GUSB, HGSNAT, GALNS, NAGLU, SGSH, gene)
|
|
E76.3 |
Mucopolysaccharidosis, Specified (GLB1, HYAL1, ARSB, GUSB, HGSNAT, GALNS, NAGLU, SGSH, geni)
|
|
E84 |
Cystic Fibrosis (CFTR, gene)
|
|
G11.3 |
Ataxialangiectasis (ATM, gene)
|
|
G12 |
Spinal Musks Atrophy and Related Syndromes (SMN1, geni)
|
|
G71.0 |
Muscular Dystrophy (DMD, geni)
|